Abstract
In a double-blind study with each patient as his own control cephapirin and cephalothin were administered to 20 patients in opposite arms for a period of 48 hr each. Neither the incidence of phlebitis nor the degree of phlebitis was significantly different with the two drugs, and there was no difference in the time of onset of pain or phlebitis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bodner S. J., Koenig M. G. Clinical and in vitro evaluation of cephapirin: a new parenteral cephalosporin. Am J Med Sci. 1972 Jan;263(1):43–51. doi: 10.1097/00000441-197201000-00007. [DOI] [PubMed] [Google Scholar]
- Bran J. L., Levison M. E., Kaye D. Clinical and in vitro evaluation of cephapirin, a new cephalosporin antibiotic. Antimicrob Agents Chemother. 1972 Jan;1(1):35–40. doi: 10.1128/aac.1.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gordon R. C., Barrett F. F., Clark D. J., Yow M. D. Laboratory and pharmacologic studies of BL-P-1322 (cephapirin sodium) in children. Curr Ther Res Clin Exp. 1971 Jun;13(6):398–406. [PubMed] [Google Scholar]
- Lane A. Z., Taggart J. G., Iles R. L. Relative incidence of phlebitis caused by continuous intravenous infusion of cephapirin and cephalothin. Antimicrob Agents Chemother. 1972 Sep;2(3):234–235. doi: 10.1128/aac.2.3.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wiesner P., MacGregor R., Bear D., Berman S., Holmes K., Turck M. Evaluation of a new cephalosporin antibiotic, cephapirin. Antimicrob Agents Chemother. 1972 Apr;1(4):303–309. doi: 10.1128/aac.1.4.303. [DOI] [PMC free article] [PubMed] [Google Scholar]